Adjuvant immunotherapy survival: Aligning eligibility, treatment assignment and time zero
Journal of the European Academy of Dermatology and Venereology · 26.10.2026
DOI: 10.1111/jdv.70805 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 26.10.2026. Verfasst von Fangrong Jiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The Affiliated Yangming Hospital of Ningbo University, Yuyao, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, The Affiliated Yangming Hospital of Ningbo University, Yuyao, China.
ORCID-Profile: Fangrong Jiang, Ting Shen
Zitieren
APA
Jiang, F., & Shen, T. (2026). Adjuvant immunotherapy survival: Aligning eligibility, treatment assignment and time zero. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70805
Vancouver
Jiang F, Shen T. Adjuvant immunotherapy survival: Aligning eligibility, treatment assignment and time zero. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70805
BibTeX
@article{Jiang2026,
author = {Jiang, Fangrong and Shen, Ting},
title = {Adjuvant immunotherapy survival: Aligning eligibility, treatment assignment and time zero},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
doi = {10.1111/jdv.70805}
}
EUVIMED